[1] McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast induced nephropathy[J]. Am J Cardiol, 2006, 98(6A):5K-13K.
[2]Shemirani H, Pourrmoghaddas M. A randomized trial of saline hydration to prevent contrast induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention[J]. Saudi J Kidney Dis Transpl, 2012, 23(2): 280-285.
[3]王尧, 况九龙. 金水宝对哮喘大鼠气道重塑、气道炎症及氧化应激水平影响的研究[J]. 江西医学院学报 2009, 49(4): 27-31.
[4]Maliborski A, Zukowski P, Nowicki G, et al. Contrast-induced nephropathy-a review of current literature and guidelines[J]. Med Sci Monit, 2011, 17(9): RA199-204.
[5]Sendeski M, Patzak A, Persson PB. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents[J]. Invest Radiol, 2010, 45(8): 453- 457.
[6]马雪平, 郝钦芳, 杨晓莉, 等. 肾脏疾病患者血清Cystatin C测定的临床价值[J]. 中国卫生检验杂志, 2007, 17(7): 1253-1254.
[7]Pöge U, Stoschus B, Stoffel-Wagner B, et al. Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients[J]. Kidney Blood Press Res, 2003, 26(1): 55- 60.
[8]陈华茜, 闵新文, 赵黎丙. 血清胱抑素C评价冠脉介入术后对比剂肾病的优越性[J]. 中国现代医学杂志, 2011, 21(33): 4165- 4167.
[9]Heyman SN, Rosen S, Khamaisi M, et al. Reactive oxygen species and the pathogenesis of radiocontrast induced nephropathy[J]. Invest Radiol, 2010, 45(4): 188-195.
[10]钟丽萍. 金水宝的临床应用及作用机理探讨[J]. 实用临床医学, 2001, 2(4): 99-100.
[11]李贵明, 徐霞,李素倩. 金水宝对肾病综合征超氧化物歧化酶及血脂的影响[J]. 泰山医学院学报, 1997, 18(4): 311-313.